Revenue
2018
2019
2020
2021
2022
2023
2024
2025
INTUITIVE SURGICAL INC (ISRG)
Price—Loading quote
Net income
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $10.06B | $8.35B | $7.12B | $6.22B | $5.71B | $4.36B | $4.48B | $3.72B | $3.14B | $2.71B | $2.38B | $2.13B | $2.27B | $2.18B | $1.76B | $1.41B | $1.05B | $874.9M | $600.8M |
| Gross profit | $6.64B | $5.63B | $4.73B | $4.20B | $3.96B | $2.86B | $3.11B | $2.60B | $2.20B | $1.89B | $1.58B | $1.41B | $1.59B | $1.57B | $1.27B | $1.03B | $751.1M | $620.8M | $414.3M |
| Research & development | $1.31B | $1.15B | $998.8M | $879.0M | $671.0M | $595.1M | $557.3M | $418.1M | $328.6M | $239.6M | $197.4M | $178.0M | $167.7M | $170.0M | $140.2M | $116.0M | $95.1M | $79.4M | $48.9M |
| Operating expenses | $3.70B | $3.29B | $2.96B | $2.62B | $2.14B | $1.81B | $1.74B | $1.40B | $1.14B | $943.2M | $837.9M | $869.0M | $741.7M | $692.2M | $579.0M | $474.8M | $373.7M | $310.0M | $207.5M |
| Operating income | $2.95B | $2.35B | $1.77B | $1.58B | $1.82B | $1.05B | $1.37B | $1.20B | $1.06B | $949.7M | $740.0M | $544.8M | $852.5M | $878.1M | $694.8M | $555.2M | $377.4M | $310.8M | $206.7M |
| EBITDAderived | $3.56B | $2.80B | $2.17B | $1.93B | $2.13B | $1.32B | $1.57B | $1.32B | $1.16B | $1.04B | $825.5M | $619.2M | $919.8M | $935.9M | $741.3M | $595.6M | $412.0M | $335.9M | $219.8M |
| Net income | $2.86B | $2.32B | $1.80B | $1.32B | $1.70B | $1.06B | $1.38B | $1.13B | $670.9M | $738.3M | $588.8M | $418.8M | $671.0M | $656.6M | $495.1M | $381.8M | $232.6M | $204.3M | $144.5M |
| Basic EPSper diluted share | $8.00 | $6.54 | $5.12 | $3.72 | $4.79 | $3.02 | $3.98 | $9.92 | $6.01 | $6.43 | $5.29 | $11.35 | $17.12 | $16.50 | $12.63 | $9.74 | $6.07 | $5.26 | $3.82 |
| Diluted EPSper diluted share | $7.87 | $6.42 | $5.03 | $3.65 | $4.66 | $2.94 | $3.85 | $9.49 | $5.77 | $6.26 | $5.18 | $11.11 | $16.73 | $15.98 | $12.32 | $9.47 | $5.93 | $5.12 | $3.70 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 12, 2026Form 4 · 10b5-1 | Brosius MarkEVP & Chief Mfg and Supply Cha | SellCommon Stock | 25 | $414.13 | $10.4K | 1.4K |
| Jun 11, 2026Form 4 · 10b5-1 | Brosius MarkEVP & Chief Mfg and Supply Cha | SellCommon Stock | 23 | $412.16 | $9.5K | 1.4K |
| Jun 10, 2026Form 4 · 10b5-1 | Brosius MarkEVP & Chief Mfg and Supply Cha | SellCommon Stock | 23 | $424.14 | $9.8K | 1.5K |
| Jun 10, 2026Form 4 · 10b5-1 | LOEB GARYEVP & Chief Legal and Complian | SellCommon Stock | 400 | $424.14 | $169.7K | 5.7K |
| Jun 9, 2026Form 4 · 10b5-1 | Brosius MarkEVP & Chief Mfg and Supply Cha | SellCommon Stock | 23 | $421.13 | $9.7K | 1.5K |